Differences in the Expression of Cathepsin B in B16 Melanoma Metastatic Variants Depend on Transcription Factor Sp1.
From: Program in Molecular Biology, Stritch School of Medicine, Loyola University of Chicago, Maywood, Illinois 60153, USA.
DNA and cell biology
- Publish Date: Sep 2007
- ISSN: 1044-5498
- Volume: 26
- Issue: 9
- Pages: 673-82
- Medium: Print
- Language: English
- Citation (JAMA): Sitabkhan Yasmin, Frankfater Allen, et al. Differences in the Expression of Cathepsin B in B16 Melanoma Metastatic Variants Depend on Transcription Factor Sp1.. DNA Cell Biol. Sep 2007;26:673-82
Abstract
Cathepsin B contributes to the invasiveness of B16 melanoma cells in mice, with the highly metastatic B16a melanoma producing six- to eightfold more cathepsin B mRNA and protein than the less metastatic B16F1 variant. The proximal promoter region of the cathepsin B (Ctsb) gene (-149 to +94) was previously found to be capable of reproducing this pattern of differential gene activation in B16 melanoma variants. The binding of B16 melanoma nuclear proteins to this promoter region has now been mapped to three GC-boxes (Sp1 transcription factor binding sites) and a potential X-box [tax response element (TRE)/c-AMP responsive element (CRE) site]. Mutation of the GC-boxes at -55 and -37 independently decreased the expression of a luciferase reporter gene in B16a cells to the level observed in B16F1 cells. Promoter activity was also attenuated by mutations within the GC-rich segment between +6 and +16, but not by mutation of the putative X-box. Both Sp1 and Sp3 bound the GC-boxes in the Ctsb promoter, and western blotting showed the level of Sp1 to be greater in B16a compared to B16F1 cells. B16F1 cells that were made to express Sp1 at levels observed in B16a cells produced corresponding increased amounts of endogenous cathepsin B mRNA and enzyme activity. Thus, the difference in cathepsin B expression between high and low metastatic B16 melanoma variants is largely due to different levels of Sp1.
Mesh Headings (Keywords): Animals, Base Composition, Base Sequence, Binding Sites, Cathepsin B, Electrophoretic Mobility Shift Assay, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Lung Neoplasms, Melanoma, Experimental, Mice, Mice, Inbred C57BL, Molecular Sequence Data, Mutagenesis, Site-Directed, Promoter Regions (Genetics), RNA, Messenger, Response Elements, Sequence Deletion, Sp1 Transcription Factor, Sp3 Transcription Factor, Trans-Activation (Genetics), Transcription, Genetic, Transfection, Tumor Cells, Cultured
Check for Full Text / PubMed Unique Identifier (PMID): 17691867
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.